Articles dans des revues avec comité de lecture (95)
9.
Mirzaei, M., Dodi, G., Gardikiotis, I., Pasca, S.-A., Mirdamadi, S., Subra, G., Echalier, C., Puel, C., Morent, R., Ghobeira, R., Soleymanzadeh, N., Moser, M., Goriely, S., & Shavandi, A. (2023). 3D high-precision melt electro written polycaprolactone modified with yeast derived peptides for wound healing. Biomaterials Advances, 149, 213361. doi:10.1016/j.bioadv.2023.21336110.
Bisilliat Donnet, C., Acolty, V., Azouz, A., Taquin, A., Henin, C., Cafarello, S. T., Denanglaire, S., Mazzone, M., Oldenhove, G., Leo, O., Goriely, S., & Moser, M. (2023). PHD2 Constrains Antitumor CD8+ T-cell Activity. Cancer immunology research, 11(3), 339-350. doi:10.1158/2326-6066.CIR-22-009911.
Davenne, T., Percier, P., Larbanoix, L., Moser, M., Leo, O., Meylan, E., Goriely, S., Gérard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosiere, R. (2022). Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. Journal of controlled release, 353, 317-326. doi:10.1016/j.jconrel.2022.11.05512.
Vogel, I., Acolty, V., Keler, T., Goriely, S., Leo, O., & Moser, M. (2022). Agonistic anti-CD27 antibody ameliorates EAE by suppressing IL-17 production. European Journal of Immunology, 52(10), 1620-1629. doi:10.1002/eji.20214969813.
Sánchez Sánchez, G., Papadopoulou, M., Azouz, A., Tafesse, Y., Mishra, A., Chan, J. K. Y., Fan, Y., Verdebout, I., Porco, S., Libert, F., Ginhoux, F., Vandekerckhove, B., Goriely, S., & Vermijlen, D. (2022). Identification of distinct functional thymic programming of fetal and pediatric human γδ thymocytes via single-cell analysis. Nature communications, 13(1), 5842. doi:10.1038/s41467-022-33488-214.
Pannus, P., Neven, K., De Craeye, S., Heyndrickx, L., Vande Kerckhove, S., Georges, D., Michiels, J., Francotte, A., Van den Bulcke, M. M., Zrein, M., Gucht, S. V., Schmickler, M.-N., Verbrugghe, M., Matagne, A., Thomas, I., Dierick, K., Martens Weiner, J. E., Ackerman, M. M., Goriely, S., Goossens, M. M., Ariën, K., Desombere, I., & Marchant, A. (2022). Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes. Clinical infectious diseases, 75(1), e695-e704. doi:10.1093/cid/ciab99815.
Brauns, E., Azouz, A., Grimaldi, D., Xiao, H., Thomas, S., Nguyen, M., Olislagers, V., Vu Duc, I., Orte Cano, C., Del Marmol, V., Pannus, P., Libert, F., Saussez, S., Dauby, N., Das, J., Marchant, A., & Goriely, S. (2022). Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19. JCI insight, 7(9). doi:10.1172/jci.insight.15418316.
Mirzaei, M., Shavandi, A., Dodi, G., Gardikiotis, I., Pasca, S.-A., Mirdamadi, S., Soleymanzadeh, N., Alimoradi, H., Moser, M., & Goriely, S. (2022). A Yeast-Derived Peptide Promotes Skin Wound Healing by Stimulating Effects on Fibroblast and Immunomodulatory Activities. SSRN Electronic Journal. doi:10.2139/ssrn.403032817.
Ajouaou, Y., Azouz, A., Taquin, A., Denanglaire, S., Hind, H. H., Krayem, M., Andris, F., Moser, M., Goriely, S., & Leo, O. (2022). The oxygen sensor Prolyl hydroxylase domain 2 regulates the in vivo suppressive capacity of regulatory T cells. eLife, 11. doi:10.7554/eLife.7055518.
Goossens, M. M., Neven, K. K., Pannus, P., Barbezange, C., Thomas, I., Gucht, S. V., Dierick, K., Schmickler, M.-N., Verbrugghe, M., Loon, N. V., Ariën, K., Marchant, A., Goriely, S., & Desombere, I. (2021). The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. Archives of public health, 79(1), 195. doi:10.1186/s13690-021-00715-z19.
Mirzaei, M., Shavandi, A., Mirdamadi, S., Soleymanzadeh, N., Motahari, P., Mirdamadi, N., Moser, M., Subra, G., Alimoradi, H., & Goriely, S. (2021). Bioactive peptides from yeast: A comparative review on production methods, bioactivity, structure-function relationship, and stability. Trends in food science & technology, 118, 297-315. doi:10.1016/j.tifs.2021.10.00820.
Canti, L., Humblet-Baron, S., Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., Servais, S., Willems, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K., Beguin, Y., Goossens, M. M., Marchant, A., & Baron, F. (2021). Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of Hematology & Oncology, 14(1). doi:10.1186/s13045-021-01190-3